Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

Rhea-AI Summary

Collegium Pharmaceutical (Nasdaq: COLL) has scheduled its second quarter 2025 financial results announcement for Thursday, August 7, 2025, before market opening. The company will host a conference call and webcast at 8:00 a.m. ET following the release.

Investors can access the conference call via (877) 407-8037 (U.S.) or (201) 689-8037 (International). An audio webcast will be available on the company's website investor section and will remain accessible for replay approximately two hours after the event.

News Market Reaction – COLL

-0.93%

-0.93% Session move

In the trading session that priced this news, COLL declined 0.93%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

STOUGHTON, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report second quarter 2025 financial results before the market opens on Thursday, August 7, 2025. Following the release of the financials, the Company will host a live conference call and webcast at 8:00 a.m. ET.

Conference Call Information 
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q2 2025 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com

Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com                        

FAQ

When will Collegium Pharmaceutical (COLL) report Q2 2025 earnings?

Collegium Pharmaceutical will report Q2 2025 earnings on Thursday, August 7, 2025, before the market opens.

How can investors access Collegium's Q2 2025 earnings call?

Investors can join via phone at (877) 407-8037 (U.S.) or (201) 689-8037 (International), or through the webcast available on Collegium's website investor section.

What time is Collegium's Q2 2025 earnings conference call?

The conference call and webcast will begin at 8:00 a.m. ET on August 7, 2025.

Where can I find the replay of Collegium's Q2 2025 earnings webcast?

The webcast replay will be available on Collegium's website (www.collegiumpharma.com) in the Investors section approximately two hours after the event.